Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings

Kaminogo M, Ishimaru H, Morikawa M et al. (2001) Diagostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 43:353–363 Luyten PR, Marien AJ, Heindel W et al. (1990) Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176:791–799 Alger JR, Frank JA, Bizzi A et al. (1990) Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633–641 Nelson SJ, Huhn S, Vigneron DB et al. (1997) Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors. Magn Reson Imaging 7:1146–1152 Vigneron DB, Bollen A, McDermott M et al. (2001) Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 19:89–101 Krabbe K, Gideon P, Wagn P, Hansen U, Thosem C, Madsen F (1997) MR diffusion imagng of human intracranial tumors. Diagn Neuroradiol 39:483–489 Roland G, Daniel B, Vigneron N et al. (2001) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366 Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotaxic serial biopsies in untreated intracranial neoplasms. J Neurosurg 66:865–874 Henry RG, Vigneron DB, Fischbein NJ et al. (2000) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366 Castillo M, Kwock L (1998) Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am8:733–752 McBride DQ, Miller BL, Nikas DL et al. (1995) Analysis of brain tumors using 1H magnetic resonance spectroscopy. Surg Neurol 44:137–144 Shimuzu H, Kumabe T, Tominaga T et al. (1996) Non-invasive evaluation of malignat brain tumors wityh proton MR spectroscopy. AJNR Am J Neuroradiol 17:737–747 Knopp EA, Cha S, Johnson G et al. (1999) Glial neoplasms: dynamic contrast enhanced T2-weighted MR imaging. Radiology 211:791–798 Tien RD, Felsberg GJ, Friedman H, Brown M, McFall J (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162:671–677 Brunberg JA, Chenevert TL, MckeeverPE et al. (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of cerebral hemispheres. AJNR Am J Neuroradiol 16:361–371 Lu S, Ahn D, Johnson G, Cha S (2003) Peritumoral diffusion tensor imaging of high- grade gliomas and metastatic brain tumos. AJNR Am J Neuroradiol 24:937–941 Steen RG (1992) Edema and tumor perfusion: characterization by quantitative proton MR imaging. AJR Am J Roentgenol 158:259–264 Zhang M, Olsson Y (1997) Hematogenous metastases of the human brain: characteristics of peritumoral brain changes—a review. J Neurooncol 35:81–89 Hossman KA, Bloink M (1981) Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 12:211–217 Burger P (1990) Classification, grading, and patterns of spread of malignant gliomas. In: Apuzzo ML (eds) Neurosurgical topics: malignant cerebral glioma. American Association of Neurological Surgeons, Park Ridge, 3–17 Aronen HJ, Gazit IE, Louis DN et al. (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51 Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK (1995) Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol 16:1593–1603 Bruhn H, Frahm J, Gyngell ML et al. (1989) Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172:541–548 Preul MC, Caramanos Z, Collins DL et al. (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323–325 Sugahara T, Korogi Y, Kochi M et al. (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479–1486 Li X, Lu y, Pirzkall A, McKnight T, Nelson S (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229–237 Ikehira H, Miyamoto T, Yasukawa T et al. (1995) Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors. Radiat Med 13:199–204 Usenius T, Usenius J, Tenhunen M et al. (1995) Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 33:719–724 Walecki J, Sokol M, Pieniazek P et al. (1999) Role of short TE 1H-MR spectroscopy in monitoring of postoperation irradiated patients. Eur J Radiol 30:154–161 Taylor JS, Langston JW, Reddick WE et al. (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251–1261 Ricci PE, Pitt A, Keller PJ, Coons SW, Heiserman JE (2000) Effect of voxel position on single-voxel MR spectroscopy findings. AJR Am J Neuroradiol 21:367–337 Meng L, Soonmee C, Knopp EA, Johnson G, Arnett BS, Litt AW (2002) High grade-gliomas and solitary metasases: differentiaition by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721